Receive The Newest Study Notifications

Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple Negative Breast Cancer

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the NSABP Foundation, Inc. (NSABP) has enrolled the first patient in the study: A Phase II Clinical Trial of Pembrolizumab in Combination...

fishbat Explains How Google Ads Can Help Boost Your Clinical Trial Recognition

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

When patients are searching for more information on ailments or medical conditions, their first stop will most likely be Google. That said, companies specializing in clinical trial patient recruitment must be cognizant of those searching habits and take advantage of...

Kura Oncology Doses First Patient In Phase 1 Clinical Trial Of Menin-MLL Inhibitor KO-539 In Acute Myeloid Leukemia

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

KO-539 is a first-in-class small molecule inhibitor of the menin-MLL interaction First-in-human trial to determine MTD, expand to genetic subgroups such as NPM1 San Diego, CA (GLOBE NEWSWIRE) – Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage...

Study indicates early infusion of mononuclear cells could aid in recovery from stroke

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Results of a clinical trial published today in STEM CELLS are the first to document the safety and feasibility of the early administration of bone marrow cells to treat acute ischemic stroke patients. DURHAM, N.C., Sept. 17, 2019 /PRNewswire-PRWeb/ — Results of...

Centrexion Therapeutics Announces Completion of Patient Enrollment in VICTORY-3 Phase 3 Open-Label Clinical Trial of CNTX-4975 in Patients with Moderate-to-Severe Osteoarthritis Knee Pain

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

– CNTX-4975 Phase 3 clinical development program fully enrolled – – VICTORY-1 pivotal and VICTORY-3 open-label topline results expected in Q1 2020; VICTORY-2 pivotal results expected in Q3 2020 – BOSTON, Sept. 17, 2019 (GLOBE NEWSWIRE) —...

Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL®

by Lance Smith | Sep 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform

GRONINGEN, The Netherlands, September 17, 2019 / B3C newswire / — Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, has today announced positive data from its ENCASE I* clinical trial. The...